These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 22791754

  • 21. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
    Fernández Sánchez M, Višnová H, Larsson P, Yding Andersen C, Filicori M, Blockeel C, Pinborg A, Khalaf Y, Mannaerts B, Rainbow Study Group.
    Hum Reprod; 2022 May 30; 37(6):1161-1174. PubMed ID: 35451013
    [Abstract] [Full Text] [Related]

  • 22. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P, Ejdrup Bredkjaer H, Westergaard LG, Yding Andersen C.
    Fertil Steril; 2010 Feb 30; 93(3):847-54. PubMed ID: 19200959
    [Abstract] [Full Text] [Related]

  • 23. Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.
    Santos-Ribeiro S, Polyzos NP, Haentjens P, Smitz J, Camus M, Tournaye H, Blockeel C.
    Hum Reprod; 2014 Aug 30; 29(8):1698-705. PubMed ID: 24939956
    [Abstract] [Full Text] [Related]

  • 24. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H, Tonch N, Simons AH, van der Veen F, Hoek A, Land JA.
    Hum Reprod; 2013 Dec 30; 28(12):3236-46. PubMed ID: 24166594
    [Abstract] [Full Text] [Related]

  • 25. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep 30; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 26. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK, Schultze-Mosgau A, Cordes T, Diedrich K, Griesinger G.
    Arch Gynecol Obstet; 2013 Oct 30; 288(4):901-4. PubMed ID: 23545834
    [Abstract] [Full Text] [Related]

  • 27. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study.
    Blockeel C, De Vos M, Verpoest W, Stoop D, Haentjens P, Devroey P.
    Hum Reprod; 2009 Nov 30; 24(11):2910-6. PubMed ID: 19617207
    [Abstract] [Full Text] [Related]

  • 28. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.
    Fertil Steril; 2013 Nov 30; 100(5):1296-302. PubMed ID: 23993928
    [Abstract] [Full Text] [Related]

  • 29. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G, Schultze-Mosgau A, Dafopoulos K, Schroeder A, Schroer A, von Otte S, Hornung D, Diedrich K, Felberbaum R.
    Hum Reprod; 2005 May 30; 20(5):1200-6. PubMed ID: 15665010
    [Abstract] [Full Text] [Related]

  • 30. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
    Friis Wang N, Bogstad JW, Petersen MR, Pinborg A, Yding Andersen C, Løssl K.
    Hum Reprod; 2023 Sep 05; 38(9):1807-1815. PubMed ID: 37354554
    [Abstract] [Full Text] [Related]

  • 31. Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial.
    Lossl K, Andersen CY, Loft A, Freiesleben NL, Bangsbøll S, Andersen AN.
    Hum Reprod; 2008 Aug 05; 23(8):1820-9. PubMed ID: 18487212
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BM, Engage Investigators.
    Reprod Biomed Online; 2010 Nov 05; 21(5):593-601. PubMed ID: 20843746
    [Abstract] [Full Text] [Related]

  • 33. Eight weeks of androgen priming by daily low-dose hCG injections before ICSI treatment in women with low ovarian reserve.
    Friis Wang N, Bogstad JW, Pors SE, Petersen MR, Pinborg A, Yding Andersen C, Løssl K.
    Hum Reprod; 2023 Apr 03; 38(4):716-725. PubMed ID: 36721920
    [Abstract] [Full Text] [Related]

  • 34. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP.
    Hum Reprod; 2016 Feb 03; 31(2):370-6. PubMed ID: 26724797
    [Abstract] [Full Text] [Related]

  • 35. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J, Andersen AN, Devroey P, Arce JC, MERIT Group.
    Hum Reprod; 2007 Mar 03; 22(3):676-87. PubMed ID: 17110397
    [Abstract] [Full Text] [Related]

  • 36. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
    Hamdine O, Macklon NS, Eijkemans MJ, Laven JS, Cohlen BJ, Verhoeff A, van Dop PA, Bernardus RE, Lambalk CB, Oosterhuis GJ, Holleboom CA, van den Dool-Maasland GC, Verburg HJ, van der Heijden PF, Blankhart A, Fauser BC, Broekmans FJ, CETRO trial study group.
    Hum Reprod; 2013 Dec 03; 28(12):3227-35. PubMed ID: 24129613
    [Abstract] [Full Text] [Related]

  • 37. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
    Barmat LI, Chantilis SJ, Hurst BS, Dickey RP.
    Fertil Steril; 2005 Feb 03; 83(2):321-30. PubMed ID: 15705369
    [Abstract] [Full Text] [Related]

  • 38. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
    Serafini P, Yadid I, Motta EL, Alegretti JR, Fioravanti J, Coslovsky M.
    Fertil Steril; 2006 Oct 03; 86(4):830-8. PubMed ID: 16963040
    [Abstract] [Full Text] [Related]

  • 39. Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study.
    Qiu Q, Huang J, Li Y, Chen X, Lin H, Li L, Yang D, Wang W, Zhang Q.
    Hum Reprod; 2020 Jun 01; 35(6):1411-1420. PubMed ID: 32383771
    [Abstract] [Full Text] [Related]

  • 40. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
    Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, Lainas TG.
    Hum Reprod; 2015 Mar 01; 30(3):684-91. PubMed ID: 25586787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.